BAIT

SENP8

DEN1, NEDP1, PRSC2, FKSG8
SUMO/sentrin specific peptidase family member 8
GO Process (1)
GO Function (1)
GO Component (2)

Gene Ontology Biological Process

Gene Ontology Molecular Function

Gene Ontology Cellular Component

Homo sapiens
PREY

CRBN

MRT2, MRT2A, AD-006
cereblon
GO Process (2)
GO Function (1)
GO Component (4)
Homo sapiens

Dosage Growth Defect

A genetic interaction is inferred when over expression or increased dosage of one gene causes a growth defect in a strain that is mutated or deleted for another gene.

Publication

Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma.

Patil A, Manzano M, Gottwein E

Genome-wide CRISPR/Cas9 screens represent a powerful approach to studying mechanisms of drug action and resistance. Cereblon modulating agents (CMs) have recently emerged as candidates for therapeutic intervention in primary effusion lymphoma (PEL), a highly aggressive cancer caused by Kaposi's sarcoma-associated herpesvirus. CMs bind to cereblon (CRBN), the substrate receptor of the cullin-RING type E3 ubiquitin ligase CRL4CRBN, and thereby trigger ... [more]

Blood Adv Jul. 23, 2019; 3(14);2105-2117 [Pubmed: 31300418]

Throughput

  • Low Throughput

Ontology Terms

  • phenotype: viability (PATO:0000169)
  • biological process: response to drug (GO:0042493)

Additional Notes

  • CRISPR method
  • Overexpression of CRBN restores LEN sensitivity in SENP8-inactivated cells.

Curated By

  • BioGRID